1. Home
  2. VC vs HRMY Comparison

VC vs HRMY Comparison

Compare VC & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visteon Corporation

VC

Visteon Corporation

HOLD

Current Price

$96.60

Market Cap

2.6B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.42

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VC
HRMY
Founded
2000
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
VC
HRMY
Price
$96.60
$37.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
9
Target Price
$129.08
$51.33
AVG Volume (30 Days)
406.6K
674.4K
Earning Date
02-17-2026
11-04-2025
Dividend Yield
1.14%
N/A
EPS Growth
N/A
50.44
EPS
11.17
3.17
Revenue
$3,759,000,000.00
$825,944,000.00
Revenue This Year
N/A
$23.11
Revenue Next Year
$3.82
$16.15
P/E Ratio
$8.68
$11.80
Revenue Growth
N/A
21.13
52 Week Low
$65.10
$25.52
52 Week High
$129.10
$40.93

Technical Indicators

Market Signals
Indicator
VC
HRMY
Relative Strength Index (RSI) 38.32 51.88
Support Level $94.25 $37.12
Resistance Level $98.06 $39.60
Average True Range (ATR) 2.29 1.11
MACD -0.22 -0.42
Stochastic Oscillator 20.38 22.37

Price Performance

Historical Comparison
VC
HRMY

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: